Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient's breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $4.9M | $18.9M |
| Gross profit | — | — | -$94,633.00 | $2.6M | $8.6M |
| Operating income | -$1.1M | -$4.3M | -$5.0M | -$12.2M | -$4.4M |
| Net income | -$1.1M | -$2.8M | -$6.1M | -$9.0M | -$21.1M |
| Diluted EPS | -$0.14 | -$0.60 | -$0.64 | -$2.13 | -$2.01 |
| Operating cash flow | -$1.4M | -$1.3M | -$2.7M | -$10.0M | -$9.0M |
| Free cash flow | — | — | -$2.7M | -$10.1M | -$9.1M |
| Gross margin | — | — | — | 54.1% | 45.4% |
| Operating margin | — | — | — | -249.6% | -23.4% |
| Net margin | — | — | — | -184.2% | -111.4% |
| Line item | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.4M | $1.7M | $955,970.00 | $846,832.00 | $2.8M | $3.7M | $4.2M | $8.3M |
| Gross profit | $760,080.00 | $874,551.00 | $605,303.00 | $400,066.00 | $1.8M | $1.8M | $1.8M | $3.1M |
| Operating income | -$5.6M | -$2.2M | -$2.3M | -$2.1M | -$1.0M | -$1.0M | -$1.7M | -$700,211.00 |
| Net income | -$628,590.00 | -$1.2M | -$3.6M | -$3.5M | -$11.1M | -$4.0M | -$4.6M | -$1.4M |
| Diluted EPS | -$0.05 | -$0.30 | -$0.51 | -$1.27 | -$0.40 | -$0.14 | -$0.47 | -$1.00 |
| Operating cash flow | -$6.0M | -$979,566.00 | -$1.9M | -$1.2M | -$3.5M | -$1.4M | -$878,750.00 | -$3.1M |
| Free cash flow | — | — | -$1.9M | — | — | — | -$878,750.00 | — |
| Gross margin | 55.8% | 51.0% | 63.3% | 47.2% | 64.7% | 49.9% | 43.0% | 38.0% |
| Operating margin | -409.5% | -129.5% | -243.4% | -242.2% | -37.2% | -28.5% | -39.4% | -8.5% |
| Net margin | -46.1% | -72.9% | -378.6% | -411.9% | -397.9% | -109.3% | -108.7% | -16.8% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-03-20 | Taylor Ross | Award | 3,500 | $0.00 | $0.00 | filing |
| 2026-03-20 | Weiner Zeev | Award | 3,500 | $0.00 | $0.00 | filing |
| 2026-03-20 | GREENE JAMES S | Award | 3,500 | $0.00 | $0.00 | filing |
| 2026-03-20 | Jennings Jay Walter· Chief Financial Officer | Award | 2,800 | $0.00 | $0.00 | filing |
| 2026-03-20 | KLOCK JOHN C JR | Award | 3,500 | $0.00 | $0.00 | filing |
| 2026-03-20 | Dinu Raluca· Chief Executive Officer | Award | 3,500 | $0.00 | $0.00 | filing |
| 2026-03-20 | Dinu Raluca· Chief Executive Officer | Award | 500,000 | $0.00 | $0.00 | filing |
| 2026-03-20 | Dinu Raluca· Chief Executive Officer | Award | 16,000 | $0.00 | $0.00 | filing |
| 2026-03-20 | Katz Avi S· Chairman | Award | 3,500 | $0.00 | $0.00 | filing |
| 2026-03-20 | Dickson Daniel | Award | 3,500 | $0.00 | $0.00 | filing |
| 2026-03-17 | Weiner Zeev | Option exercise | 14,166 | $2.00 | $28,261.17 | filing |
| 2026-03-17 | Weiner Zeev | Option exercise | 8,888 | $2.25 | $19,955.34 | filing |
| 2026-01-22 | Katz Avi S· CHAIRMAN | Buy | 24,107 | $6.43 | $155,008.01 | filing |
Latest 13 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.